Uluru Inc., of Addison, Texas, said Ironridge Global BioPharma and its affiliates committed in two transactions to purchase common and preferred stock totaling up to $1.6 million. One of the transactions includes a purchase of up to $650,000 in convertible, redeemable, preferred stock with a 7.5 percent dividend.